Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Biochemical Pharmacology

• Publication date

  1984-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(84)90295-8PMID 6203537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Species differences in behavioural effects of rolipram and other adenosine cyclic 3h, 5h-monophosphate phosphodiesterase inhibitors

  2005cited by this paper
• Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors

  2004cited by this paper
• Neurotropic effects of the optical isomers of the selective adenosine cyclic 3′,5′‐monophosphate phosphodiesterase inhibitor rolipram in rats in‐vivo

  1983cited by this paper
• Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.

  1983cited by this paper
• The effect of various centrally active drugs on adenosine uptake by the central nervous system.

  1982cited by this paper
• Endogenous Peptides That Inhibit Brain Cyclic AMP Phosphodiesterase

  1982cited by this paper
• Cyclic AMP-generating systems: regional differences in activation by adrenergic receptors in rat brain

  1981cited by this paper
• Adenosine receptor-mediated inhibition of rat cerebral cortical adenylate cyclase by a GTP-dependent process.

  1980cited by this paper
• In vivo effects of apomorphine and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on cyclic nucleotides in rat brain and pituitary.

  1980cited by this paper
• Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines.

  1979cited by this paper
• Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity.

  1979cited by this paper
• The enzymatic preparation of [alpha-32P]ATP, [alpha-32P]GTP, [32P]cAMP, and [32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases.

  1979cited by this paper
• Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.

  1978cited by this paper
• PSYCHOLOGICAL STRESS REDUCES CYCLIC 3′,5′‐ADENOSINE MONOPHOSPHATE LEVELS IN THE CEREBRAL CORTEX OF CONSCIOUS RATS, AS DETERMINED BY A NEW CRYOGENIC METHOD OF RAPID TISSUE FIXATION 1

  1978cited by this paper
• Regional levels of cyclic AMP in rat brain: pitfalls of microwave inactivation.

  1977cited by this paper
• CYCLIC NUCLEOTIDE PHOSPHODIESTERASE IN RAT NEOSTRIATUM: MULTIPLE ISOELECTRIC FORMS WITH SIMILAR KINETIC PROPERTIES

  1976cited by this paper
• 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.

  1976cited by this paper
• Relationship between adenosine concentration and oxygen supply in rat brain.

  1975cited by this paper
• Effects of stress on rat brain adenosine 3',5'-monophosphate in vivo.

  1975cited by this paper
• [Experimental studies on mechanism of inhibition of thrombocyte aggregation caused by sulfonyl ureas. 1. Problems and methods].

  1975cited by this paper
• Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure--activity relationships, and possible role in drug development.

  1975cited by this paper
• Cyclic 3’, 5’-AMP Phosphodiesterase in Isolated Fat Cells

  1972cited by this paper
• Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.

  1972cited by this paper
• Cyclic 3',5'-AMP phosphodiesterase in isolated fat cells. Simple and sensitive methods for the assay of phosphodiesterase activity in fat cells and studies of the enzyme inhibition by theophylline.

  1972cited by this paper
• Different sensitivities of the phosphodiesterases (adenosine-3',5'-cyclic phosphate 3'-phosphohydrolase) of dog cerebral cortex and erythrocytes to inhibition by synthetic agents and cold.

  1971cited by this paper

• The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors

  2021cites this paper
• Phosphodiesterase-4D Knockdown in the Prefrontal Cortex Alleviates Memory Deficits and Synaptic Failure in Mouse Model of Alzheimer’s Disease

  2021cites this paper
• A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling

  2019cites this paper
• G&agr;i and G&bgr;&ggr; subunits have opposing effects on dexmedetomidine‐induced sedation

  2018cites this paper
• The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice

  2017cites this paper
• Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases.

  2017cites this paper
• Genistein attenuates isoflurane-induced neurotoxicity and improves impaired spatial learning and memory by regulating cAMP/CREB and BDNF-TrkB-PI3K/Akt signaling

  2017cites this paper
• Procyanidins protects against oxidative damage and cognitive deficits after traumatic brain injury

  2014cites this paper
• Inhibition of Cyclic Nucleotide Phosphodiesterases to Regulate Memory

  2014cites this paper
• The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats.

  2014cites this paper
• Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule

  2014cites this paper
• Impaired Spatial Learning and Memory after Sevoflurane–Nitrous Oxide Anesthesia in Aged Rats Is Associated with Down-Regulated cAMP/CREB Signaling

  2013cites this paper
• Analysis of new potential markers for the immediate evalua-tion of electrochemotherapy using small animal imaging

  2012cites this paper
• Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP Signaling

  2011cites this paper
• Role of Neuropeptide Y in Depression: Current Status

  2011cites this paper
• Inhibition of phosphodiesterase-4 decreases ethanol intake in mice

  2011influential citation
• Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs.

  2009cites this paper
• Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation

  2009cites this paper
• The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens

  2009influential citation
• The role of adenosine A(1) receptors in mediating the inhibitory effects of low frequency stimulation of perforant path on kindling acquisition in rats.

  2009cites this paper
• Repeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus.

  2009cites this paper
• The type 4 phosphodiesterase inhibitors rolipram and YM976 facilitate recall of the weak version of the passive avoidance task in the day-old chick.

  2009cites this paper
• The Role of Phosphodiesterases in Schizophrenia

  2008cites this paper
• A dissertation for the Degree of Master Phosphodiesterase 4D Inhibition Induces Cell Cycle Arrest and Neural Differentiation via cAMP/PKA Signaling in Primary Glioblastoma Multiforme

  2008cites this paper
• Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme

  2008cites this paper
• Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme

  2007cites this paper
• Behavioral phenotypes of Disc1 missense mutations in mice.

  2007cites this paper
• Phosphodiesterase 10A inhibitors as a novel therapeutic approach for schizophrenia

  2007cites this paper
• Effects of the phosphodiesterase inhibitor rolipram on the acoustic startle response in rats

  2006cites this paper
• Phosphodiesterase-4 as a Pharmacological Target Mediating Antidepressant and Cognitive Effects on Behavior

  2006cites this paper
• Subchronic Rolipram Delivery Activates Hippocampal CREB and Arc, Enhances Retention and Slows Down Extinction of Conditioned Fear

  2006cites this paper
• Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells.

  2006cites this paper
• Chronic treatment with the potential antidepressant drug rolipram: the effect on the behavioural responses to adrenergic and dopaminergic receptor agonists with some biochemical correlates

  2005cites this paper
• Tyrosine phosphorylation of the N-methyl-D-aspartate receptor is enhanced in synaptic membrane fractions of the adult rat hippocampus.

  2005cites this paper
• Effect of rolipram on relative 14C-deoxyglucose uptake in inflammatory lesions and skeletal muscle

  2005cites this paper
• Effects of chronic treatment with a cyclic AMP-selective phosphodiesterase inhibitor, rolipram, on excitatory amino acid neurotransmission systems in young and aged rat brains

  2005cites this paper
• Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase

  2005cites this paper
• Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram

  2004cites this paper
• The Type IV phosphodiesterase inhibitor rolipram interferes with drug‐induced conditioned place preference but not immediate early gene induction in mice

  2004cites this paper
• The Type IV-Specific Phosphodiesterase Inhibitor Rolipram and Its Effect on Hippocampal Long-Term Potentiation and Synaptic Tagging

  2004cites this paper
• Rolipram forms a potent discriminative stimulus in drug discrimination experiments in rats

  2004cites this paper
• Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors

  2003cites this paper
• Effect of rolipram on muscarinic acetylcholine receptor binding in the intact mouse brain

  2003cites this paper
• Enhancement of the relative uptake of18F-FDG in mouse fibrosarcoma by rolipram

  2002cites this paper
• Melatonin alters behavior and cAMP levels in nucleus accumbens induced by cocaine treatment.

  2002cites this paper
• Rolipram depresses [3H]2-deoxyglucose uptake in mouse brain and heart in vivo

  2002cites this paper
• Effects of rolipram on in vivo dopamine receptor binding

  2002cites this paper
• Differences in sperm motion between high- and low-shuttlebox avoidance rats (Hatano strains).

  2002cites this paper
• Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism‐induced defects in memory function and cerebral cyclic AMP signal transduction system in rats

  2002cites this paper
• Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor

  2001influential citation
• Pentoxifylline improves learning and memory in glutamate-lesioned rats.

  2000cites this paper
• Inhibition of Cyclic AMP Phosphodiesterase (PDE4) Reverses Memory Deficits Associated with NMDA Receptor Antagonism

  2000cites this paper
• Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain.

  2000cites this paper
• Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats

  2000cites this paper
• Preliminary evidence for an involvement of the cholinergic system in the sedative effects of rolipram in rats.

  1999cites this paper
• The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration.

  1999cites this paper
• Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.

  1999cites this paper
• Effects of rolipram on the elevated plus-maze test in rats: a preliminary study

  1999cites this paper
• Age-related effects of rolipram on [3H]quinuclidinyl benzilate and [3H]phorbol 12,13-dibutyrate binding in the rat brain.

  1998cites this paper
• Rolipram, an antidepressant that increases the availability of cAMP, transiently enhances wakefulness in rats.

  1998cites this paper
• Effect of rolipram on age-related changes in cyclic AMP-selective phosphodiesterase in the rat brain: an autoradiographic study.

  1998cites this paper
• Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases.

  1997cites this paper
• Dissociation of hypnotic-anesthetic actions of α2 agonists from cyclic AMP in the rat

  1997cites this paper
• Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents.

  1997cites this paper
• Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats.

  1997cites this paper
• Molecular cloning and expression of a human phosphodiesterase 4C.

  1997cites this paper
• Age‐related Changes in [3H]Nimodipine and [3H]Rolipram Binding in the Rat Brain

  1997cites this paper
• Dissociation of hypnotic-anesthetic actions of alpha 2 agonists from cyclic AMP in the rat.

  1997cites this paper
• Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor.

  1996cites this paper
• Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram.

  1996cites this paper
• 12 – Characterization of Different States of PDE4 by Rolipram and RP 73401

  1996cites this paper
• Phosphodiesterase type IV inhibitors.

  1996cites this paper
• Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.

  1995cites this paper
• Involvement of cyclic AMP at the level of the nucleus reticularis pontis caudalis in the acoustic startle response.

  1995cites this paper
• Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil.

  1995cites this paper
• Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram.

  1995cites this paper
• Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol.

  1995cites this paper
• Effects of repeated administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, on acetylcholinergic indices in the aged rat brain.

  1993cites this paper
• Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase.

  1993cites this paper
• Alterations in the binding of the phosphodiesterase inhibitor, rolipram, after transient ischemia in the gerbil brain.

  1993cites this paper
• Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat.

  1992cites this paper
• Pharmacology of second messengers: a critical appraisal.

  1992cites this paper
• Autoradiographic analysis of cyclic adenosine monophosphate phosphodiesterase using [3H]rolipram in the postischemic rat brain.

  1992cites this paper
• Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones.

  1991cites this paper
• Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding.

  1991cites this paper
• Bronchial vs. cardiovascular activities of selective phosphodiesterase inhibitors in the anesthetized beta-blocked dog.

  1991cites this paper
• Correlation of 3H-Rolipram Binding to a Cerebral cAMP Phosphodiesterase with Antidepressant Activity

  1990cites this paper
• Effects of lithium and rolipram enantiomers on locomotor activity in inbred mice.

  1990cites this paper
• Effects of novel catechol ether imidazolidinones on calcium‐independent phosphodiesterase activity, [3H]rolipram binding, and reserpine‐induced hypothermia in mice

  1990cites this paper
• Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.

  1989cites this paper
• Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant [3H]rolipram.

  1989cites this paper
• [Effects in animal models of depression of lisuride alone and upon coadministration with antidepressants].

  1989cites this paper
• The effect of a selective phosphodiesterase inhibitor, rolipram, on muricide in olfactory bulbectomized rats.

  1988cites this paper
• Defective Second-messenger Function in the Etiology of Endogenous Depression: Novel Therapeutic Approaches

  1988cites this paper
• Sensitivity of a cAMP PDE to Rolipram in Different Organs

  1987cites this paper
• Rolipram as a discriminative stimuli: transfer to phosphodiesterase inhibitors.

  1987cites this paper
• Effects of forskolin on spontaneous behavior, rectal temperature and brain cAMP levels of rats: interaction with rolipram.

  1987cites this paper
• Stereospecific binding of the antidepressant rolipram to brain protein structures.

  1986cites this paper
• Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.

  1986cites this paper
• The role of spinal cord cyclic AMP in the acoustic startle response in rats

  1986cites this paper